RANI Rani Therapeutics Holdings,...

Nasdaq ranitherapeutics.com


$ 1.55 nm (nm)    

Thursday, 20-Nov-2025 15:55:18 EST
QQQ $ 586.41 $ -14.20 (-2.37 %)
DIA $ 458.72 nm (nm)
SPY $ 653.54 $ -10.10 (-1.52 %)
TLT $ 89.27 $ 0.35 (0.39 %)
GLD $ 374.73 nm (nm)
$ 1.75
$ 1.77
$ 1.55 x 1,461
$ 1.56 x 2,500
$ 1.54 - $ 1.81
$ 0.39 - $ 3.87
3,186,267
na
212.65M
$ 0.46
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 05-13-2025 03-31-2025 10-Q
4 03-31-2025 12-31-2024 10-K
5 11-14-2024 09-30-2024 10-Q
6 08-06-2024 06-30-2024 10-Q
7 05-06-2024 03-31-2024 10-Q
8 03-20-2024 12-31-2023 10-K
9 11-08-2023 09-30-2023 10-Q
10 08-11-2023 06-30-2023 10-Q
11 05-10-2023 03-31-2023 10-Q
12 03-22-2023 12-31-2022 10-K
13 11-10-2022 09-30-2022 10-Q
14 08-10-2022 06-30-2022 10-Q
15 05-11-2022 03-31-2022 10-Q
16 03-30-2022 12-31-2021 10-K
17 11-16-2021 09-30-2021 10-Q
18 09-13-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 rani-therapeutics-hldgs-q3-eps-012-beats-015-estimate

Cash, cash equivalents and marketable securities as of September 30, 2025 totaled $4.1 million, compared to $27.6 million for t...

 4-biotech-stocks-lifting-off-as-momentum-builds

Biotech stocks have trailed the broader market this year, but more names are starting to show strength as the rally expands and...

 hc-wainwright--co-assumes-rani-therapeutics-hldgs-at-buy-announces-price-target-of-11

HC Wainwright & Co. analyst Brandon Folkes assumes Rani Therapeutics Hldgs (NASDAQ:RANI) with a Buy rating and announces...

 maxim-group-maintains-buy-on-rani-therapeutics-hldgs-raises-price-target-to-10

Maxim Group analyst Michael Okunewitch maintains Rani Therapeutics Hldgs (NASDAQ:RANI) with a Buy and raises the price targe...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION